Pharmaceutical Good Manufacturing Practice Regulations Article 126

All design changes and modifications of manufacturers shall be identified, documented, reviewed and approved by authorized personnel before their implementation.
中文原文 藥物優良製造準則第126條
製造業者之所有設計變更與修改,於實施前應予鑑別、記載及審查,並經被授權人員核准。

English translation for reference only; the Chinese text prevails. Not legal advice.